SGHT Shares Rise on Meta-Analysis Showing OMNI's Long-Term Benefits
Key Takeaways SGHT announced a published meta-analysis validating OMNI's long-term safety and efficacy.SGHT's OMNI was shown to reduce IOP and medication use with durable outcomes.SGHT reported that nearly 89% of patients achieved at least 20% IOP reduction at 6, 12 and 24 months.Sight Sciences (SGHT) recently announced the publication of a systematic literature review and meta-analysis in the European Journal of Ophthalmology, highlighting the long-term safety and efficacy of the OMNI Surgical System (OMNI ...